人类嵌合体胚胎的滋养外胚层细胞显示凋亡水平升高和分化能力受损:其生殖命运的分子线索?
这项前瞻性队列研究通过免疫荧光共定位检测64枚捐赠囊胚(13枚整倍体、22枚嵌合体、18枚非整倍体等)的凋亡与分化标志物,发现嵌合体和非整倍体囊胚的滋养外胚层(TE)细胞凋亡比例显著高于整倍体,且TE细胞保留NANOG表达的比例从整倍体到嵌合体再到非整倍体逐渐增加。研究提示非整倍体对囊胚凋亡和分化能力存在细胞谱系特异性效应,支持克隆清除假说。
要点
- 嵌合体和非整倍体囊胚的TE细胞caspase-3+比例显著高于整倍体囊胚。
- TE细胞保留NANOG表达的比例从整倍体到嵌合体再到非整倍体逐渐增加。
- ICM中caspase-3+细胞罕见,仅见于嵌合体和非整倍体囊胚且差异无统计学显著性。
核心结论
- 嵌合体和非整倍体囊胚的TE细胞凋亡水平显著高于整倍体囊胚,分化能力显著降低。
- 非整倍体对囊胚凋亡和分化能力存在细胞谱系特异性效应,支持克隆清除假说解释嵌合体胚胎的生殖潜能。
研究设计与样本
- 前瞻性队列研究,采用免疫荧光共定位细胞谱系与凋亡标志物。
- 纳入2019年9月至2022年10月在IVI-RMA Valencia接受体外受精联合PGT-A治疗的43对夫妇捐赠的64枚受精后第5或第6天囊胚,其中分析27枚嵌合体囊胚。
- 研究分两阶段:第一阶段用caspase-3检测53枚囊胚(13枚整倍体、22枚嵌合体、18枚非整倍体);第二阶段用TUNEL检测11枚囊胚(2枚整倍体、5枚嵌合体、4枚非整倍体)。
主要发现
- 第一阶段:嵌合体囊胚的总细胞数(5 dpf 49.6 ± 15个;6 dpf 58.8 ± 16.9个)、TE细胞数(5 dpf 38.8 ± 13.7个;6 dpf 49.2 ± 16.2个)和ICM细胞数(5 dpf 10.9 ± 4.2个;6 dpf 9.7 ± 7.1个)与整倍体和非整倍体囊胚相似(P > 0.05)。
- TE细胞保留NANOG表达的比例从整倍体囊胚(5 dpf 9.7% = 63/651细胞;6 dpf 0% = 0/157细胞)到嵌合体囊胚(5 dpf 13.1% = 104/794细胞;6 dpf 3.4% = 12/353细胞)再到非整倍体囊胚(5 dpf 27.9% = 149/534细胞;6 dpf 4.6% = 19/417细胞)逐渐增加(P < 0.05)。
- TE层面caspase-3+细胞常见(39% = 901/2310细胞);嵌合体囊胚(5 dpf 44.1% ± 19.6;6 dpf 43% ± 16.8)和非整倍体囊胚(5 dpf 45.9% ± 16.1;6 dpf 49% ± 15.1)的caspase-3+ TE细胞比例显著高于整倍体囊胚(5 dpf 26.6% ± 16.6;6 dpf 17.5% ± 14.8)(P < 0.05)。
- ICM层面caspase-3+细胞罕见(1.9% = 11/596细胞),仅见于嵌合体囊胚(2.6% = 6/232细胞)和非整倍体囊胚(2.5% = 5/197细胞)(P > 0.05)。
- 第二阶段:TUNEL+细胞仅见于TE细胞(32.4% = 124/383细胞);嵌合体囊胚(37.2% ± 21.9)和非整倍体囊胚(39% ± 41.7)的TE中TUNEL+细胞比例较整倍体囊胚(23% ± 32.5)呈升高趋势,但差异未达统计学显著(P > 0.05)。
局限性
- 观察到的凋亡和分化效应可能并非非整倍体细胞所独有。
- 非整倍体类型的变异以及未探索的囊胚发育和核型一致性相关因素可能引入潜在偏倚和不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are there cell lineage-related differences in the apoptotic rates and differentiation capacity of human blastocysts diagnosed as euploid, mosaic, and aneuploid after preimplantation genetic testing for aneuploidy (PGT-A) based on concurrent copy number and genotyping analysis? SUMMARY ANSWER: Trophectoderm (TE) cells of mosaic and aneuploid blastocysts exhibit significantly higher levels of apoptosis and significantly reduced differentiation capacity compared to those of euploid blastocysts. WHAT IS KNOWN ALREADY: Embryos diagnosed as mosaic after PGT-A can develop into healthy infants, yet understanding the reasons behind their reproductive potential requires further research. One hypothesis suggests that mosaicism can be normalized through selective apoptosis and reduced proliferation of aneuploid cells, but direct evidence of these mechanisms in human embryos is lacking. Additionally, data interpretation from studies involving mosaic embryos has been hampered by retrospective analysis methods and the high incidence of false-positive mosaic diagnoses stemming from the use of poorly specific PGT-A platforms. STUDY DESIGN, SIZE, DURATION: Prospective cohort study performing colocalization of cell-lineage and apoptotic markers by immunofluorescence (IF). We included a total of 64 human blastocysts donated to research on Day 5 or 6 post-fertilization (dpf) by 43 couples who underwent in vitro fertilization treatment with PGT-A at IVI-RMA Valencia between September 2019 and October 2022. A total of 27 mosaic blastocysts were analyzed. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study consisted of two phases: Phase I (caspase-3, n = 53 blastocysts): n = 13 euploid, n = 22 mosaic, n = 18 aneuploid. Phase II (terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL), n = 11 blastocysts): n = 2 euploid, n = 5 mosaic, n = 4 aneuploid. Following donation for research, vitrified blastocysts were warmed, cultured until re-expansion, fixed, processed for IF, and imaged using confocal microscopy. For each blastocyst, the following cell counts were conducted: total cells (DAPI+), TE cells (GATA3+), inner cell mass (ICM) cells (GATA3-/NANOG+), and apoptotic cells (caspase-3+ or TUNEL+). The incidence of apoptosis was calculated for each blastocyst by dividing the number of caspase-3+ cells (Phase I) or TUNEL+ cells (Phase II) by the number of TE or ICM cells. Statistical analysis was performed according to data type and distribution (P < 0.05 was considered statistically significant). MAIN RESULTS AND THE ROLE OF CHANCE: Phase I: Mosaic blastocysts displayed a similar number of total cells (49.6 ± 15 cells at 5 dpf; 58.8 ± 16.9 cells at 6 dpf), TE cells (38.8 ± 13.7 cells at 5 dpf; 49.2 ± 16.2 cells at 6 dpf), and ICM cells (10.9 ± 4.2 cells at 5 dpf; 9.7 ± 7.1 cells at 6 dpf) compared to euploid and aneuploid blastocysts (P > 0.05). The proportion of TE cells retaining NANOG expression increased gradually from euploid blastocysts (9.7% = 63/651 cells at 5 dpf; 0% = 0/157 cells at 6 dpf) to mosaic blastocysts (13.1% = 104/794 cells at 5 dpf; 3.4% = 12/353 cells at 6 dpf) and aneuploid blastocysts (27.9% = 149/534 cells at 5 dpf; 4.6% = 19/417 cells at 6 dpf) (P < 0.05). At the TE level, caspase-3+ cells were frequently observed (39% = 901/2310 cells). The proportion of caspase-3+ TE cells was significantly higher in mosaic blastocysts (44.1% ± 19.6 at 5 dpf; 43% ± 16.8 at 6 dpf) and aneuploid blastocysts (45.9% ± 16.1 at 5 dpf; 49% ± 15.1 at 6 dpf) compared to euploid blastocysts (26.6% ± 16.6 at 5 dpf; 17.5% ± 14.8 at 6 dpf) (P < 0.05). In contrast, at the ICM level, caspase-3+ cells were rarely observed (1.9% = 11/596 cells), and only detected in mosaic blastocysts (2.6% = 6/232 cells) and aneuploid blastocysts (2.5% = 5/197 cells) (P > 0.05). Phase II: Consistently, TUNEL+ cells were only observed in TE cells (32.4% = 124/383 cells). An increasing trend was identified toward a higher proportion of TUNEL+ cells in the TE of mosaic blastocysts (37.2% ± 21.9) and aneuploid blastocysts (39% ± 41.7), compared to euploid blastocysts (23% ± 32.5), although these differences did not reach statistical significance (P > 0.05). LIMITATIONS, REASONS FOR CAUTION: The observed effects on apoptosis and differentiation may not be exclusive to aneuploid cells. Additionally, variations in aneuploidies and unexplored factors related to blastocyst development and karyotype concordance may introduce potential biases and uncertainties in the results. WIDER IMPLICATIONS OF THE FINDINGS: Our findings demonstrate a cell lineage-specific effect of aneuploidy on the apoptotic levels and differentiation capacity of human blastocysts. This contributes to unravelling the biological characteristics of mosaic blastocysts and supports the concept of clonal depletion of aneuploid cells in explaining their reproductive potential. STUDY FUNDING/COMPETING INTEREST(S): This work was funded by grants from Centro para el Desarrollo Tecnológico Industrial (CDTI) (20190022) and Generalitat Valenciana (APOTIP/2019/009). None of the authors has any conflict of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Martín Á, Mercader A, Beltrán D, et al. Trophectoderm cells of human mosaic embryos display increased apoptotic levels and impaired differentiation capacity: a molecular clue regarding their reproductive fate? Hum Reprod. 2024. PMID: 38308811. doi:10.1093/humrep/deae009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。